Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Stabilus SE

Start price
Target price
Perf. (%)
€56.85
28.01.22
€62.00
28.01.23
13.28%
29.01.23

Could be worthwhile Investment >10% per year
buy
Rheinmetall AG

Start price
Target price
Perf. (%)
€93.66
27.01.22
€104.00
27.07.22
138.95%
29.06.22

Top 10 in its market
Stable Large shareholder and/or long term investor
Differentiated customer and product portfolio
Revenue growth >5% per year expected
buy
Signature Bank

Start price
Target price
Perf. (%)
€274.00
27.01.22
-
27.01.23
-57.77%
28.01.23

buy
Quoin Pharmaceuticals Ltd. ADR

Start price
Target price
Perf. (%)
€13.88
25.01.22
€25.00
25.01.23
9.01%
05.02.22

Could be worthwhile Investment >10% per year
Good culture
Capable Management
Few uniques
buy
Encavis AG

Start price
Target price
Perf. (%)
€13.53
25.01.22
-
25.01.23
3.25%
25.02.22

buy
Wacker Chemie AG

Start price
Target price
Perf. (%)
€123.50
25.01.22
-
25.01.23
4.94%
25.02.22

buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€134.45
25.01.22
€200.00
25.01.23
16.36%
05.02.22

Rising EBIT margin expected
Good rating
High Investments for future growth
Valuable balance sheet
buy
Commerzbank AG

Start price
Target price
Perf. (%)
€7.25
25.01.22
-
25.01.23
33.57%
26.01.23

buy
Evonik Industries AG

Start price
Target price
Perf. (%)
€28.58
24.01.22
-
24.01.26
-40.08%
11.03.24

Could be worthwhile Investment >10% per year
Zoom Video Communications Inc

Start price
Target price
Perf. (%)
€124.20
24.01.22
€112.00
24.01.23
3.83%
30.01.22

Top 10 in its market
Future proof or reliable business model
negative Cash Flow expected
Significant cyclical dependencies
Aecom Tech.c.(del.)

Start price
Target price
Perf. (%)
€62.50
24.01.22
€57.00
24.01.23
12.00%
16.03.22

Higher EBIT margin than peer group
Fair valuation
ROE higher than 10% per year
Good rating
Boston Beer Company Inc.

Start price
Target price
Perf. (%)
€390.00
24.01.22
€290.00
24.01.23
-6.82%
26.11.22

Good rating
Standard Investments for future growth
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Teladoc Health Inc

Start price
Target price
Perf. (%)
€60.46
24.01.22
€52.00
24.01.23
5.86%
30.01.22

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
buy
Altice NV

Start price
Target price
Perf. (%)
€5.34
24.01.22
-
-
26.01.21

Could be worthwhile Investment >10% per year
buy
Pan American Silver Corp.

Start price
Target price
Perf. (%)
€20.94
24.01.22
-
24.01.23
-8.88%
05.02.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Cronos Group Inc.

Start price
Target price
Perf. (%)
€3.03
24.01.22
-
24.01.23
18.13%
28.03.22

Could be very worthwhile Investment >20% year
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€131.05
23.01.22
-
23.01.23
19.38%
06.02.22

Could be very worthwhile Investment >20% year
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€137.00
23.01.22
-
23.01.23
4.37%
06.02.22

Could be very worthwhile Investment >20% year
buy
Cronos Group Inc.

Start price
Target price
Perf. (%)
€3.03
23.01.22
-
23.01.23
6.03%
06.02.22

Could be very worthwhile Investment >20% year
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€6.43
23.01.22
-
23.01.23
7.21%
06.02.22

Could be very worthwhile Investment >20% year
buy
Tilray Inc

Start price
Target price
Perf. (%)
€5.18
23.01.22
-
23.01.23
2.35%
06.02.22

Could be very worthwhile Investment >20% year
buy
Gamesa Corp.

Start price
Target price
Perf. (%)
€16.75
23.01.22
-
23.01.23
2.57%
09.02.22

Could be worthwhile Investment >10% per year
buy
Nordex SE ADR

Start price
Target price
Perf. (%)
€6.00
23.01.22
-
23.01.23
5.83%
04.02.22

Could be worthwhile Investment >10% per year
High valuation
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€131.05
22.01.22
€150.00
22.01.23
19.38%
06.02.22

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
Standard Investments for future growth
Capable Management
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€137.00
22.01.22
€165.00
22.01.23
4.37%
06.02.22

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business